| Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit (NCT05171257) | Methodist Health System | 2021-10-19 |
| The Clinical Character，Risk and Prognosis of Post-neurosurgical Intracranial Infection With Different Pathogens. (NCT04917380) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-06-10 |
| Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections (NCT04785924) | Wake Forest University Health Sciences | 2021-06-07 |
| Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection (NCT04861922) | The Third Xiangya Hospital of Central South University | 2021-05-11 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants (NCT04335539) | Shionogi | 2020-08-21 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants (NCT04215991) | Shionogi | 2020-02-19 |
| Comparison of Solid Organ Transplant (NCT04055922) | Methodist Health System | 2018-05-03 |
| A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting (NCT03160040) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2017-10-11 |
| A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants (NCT03182504) | Hoffmann-La Roche | 2017-06-15 |
| Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections (NCT03397914) | National Cancer Institute, Egypt | 2017-01-01 |
| An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT (NCT02962934) | Royal Brisbane and Women's Hospital | 2016-11-30 |
| Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread (NCT02666274) | Guy's and St Thomas' NHS Foundation Trust | 2015-12-01 |
| Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant (NCT02088840) | Gruppo Italiano Trapianto di Midollo Osseo | 2014-01-01 |
| Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem (NCT01732250) | Mical Paul | 2013-03-01 |
| Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients (NCT01600768) | National Taiwan University Hospital | 2012-02-01 |
| Temocillin Pharmacokinetic in Hemodialysis (NCT02285075) | AZ Sint-Jan AV | 2011-06-01 |
| Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients (NCT00723502) | MerLion Pharmaceuticals GmbH | 2008-09-01 |
| Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-negative Bloodstream Isolates (NCT00394784) | University of Pittsburgh | 2006-12-01 |
| The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial (NCT00490477) | University of Turin, Italy | 2006-05-01 |
| Early-Onset Sepsis Surveillance Study (NCT00874367) | NICHD Neonatal Research Network | 2006-02-01 |
| A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-negative Sepsis in Adult (NCT00563134) | Hospital Authority, Hong Kong | 2005-10-01 |
| Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit (NCT00177814) | University of Pittsburgh | 2005-09-01 |
| Gram Negative Bacteremia, Risk Factors for Failure of Therapy (NCT00177957) | University of Pittsburgh | 2005-04-01 |
| Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis (NCT00629382) | St. Bortolo Hospital | 2004-12-01 |
| Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms (NCT00079989) | Wyeth is now a wholly owned subsidiary of Pfizer | 2003-12-01 |
| Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis (NCT00406198) | Hopital Lariboisière | 1997-03-01 |